Bio­gen of­fers to buy out strug­gling neu­ro part­ner Sage Ther­a­peu­tics

Bio­gen has made an of­fer to ac­quire its part­ner Sage Ther­a­peu­tics, ac­cord­ing to a Fri­day evening reg­u­la­to­ry dis­clo­sure, fol­low­ing months of set­backs by the small­er …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER